Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CCELCRYO CELL INTERNATIONAL INC

NYSE · CIK 0000862692
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC8090 Services-Misc Health & Allied Services, NEC
FY end1130
XBRL facts409

Identity from submissions API

NameCRYO CELL INTERNATIONAL INC
CIK0000862692
TickersCCEL
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC8090 Services-Misc Health & Allied Services, NEC
EIN223023093
LEI—
Fiscal year end1130
State of incorporationDE DE
Phone813-749-2104
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • CRYO CELL INTERNATIONAL INC (1997-10-17T04:00:00.000Z → 2026-10-28T04:00:00.000Z)
Business address
700 BROOKER CREEK BLVD
SUITE 1800
OLDSMAR
FL
34677
FL
Mailing address
700 BROOKER CREEK BLVD
SUITE 1800
OLDSMAR
FL
34677
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

908 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-10-28 8-K 8-K 5.07 0001193125-26-436296 001-40767 261496498 34 159248 1 1
2026-10-28 4 4 0001193125-26-436298 11905
2026-10-28 4 4 0001193125-26-436297 15527
2026-10-13 DEF 14A DEF 14A 0001193125-26-420608 001-40767 261457533 34 5882734 1 1
2026-10-13 ARS ARS 0001193125-26-420607 001-40767 261457517 34 918216
2026-10-09 10-Q 10-Q 0001193125-26-419156 001-40767 261453253 34 12175135 1 1
2026-09-14 8-K 8-K 8.01 0001193125-26-390647 001-40767 261377724 34 148297 1 1
2026-08-07 4 4 0001193125-26-340392 26901
2026-07-15 10-Q 10-Q 0001193125-26-304834 001-40767 261177702 34 11499579 1 1
2026-07-07 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-032265 005-80299 261157952 34 46577
2026-05-29 4 4 0001193125-26-248432 15346
2026-05-08 8-K 8-K 3.01,7.01,9.01 0001193125-26-214569 001-40767 26958067 34 179790 1 1
2026-04-14 10-Q 10-Q 0001193125-26-155057 001-40767 26861502 34 10406468 1 1
2026-03-25 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-012763 005-80299 26794166 34 42412
2026-03-12 8-K 8-K 3.01,7.01,9.01 0001193125-26-104392 001-40767 26748781 34 182037 1 1
2026-02-27 10-K 10-K 0001193125-26-083096 001-40767 26701444 34 15233880 1 1
2026-01-09 4 4 0001193125-26-009073 25022
2026-01-09 4 4 0001193125-26-009069 17849
2026-01-09 4 4 0001193125-26-009068 19540
2026-01-09 4 4 0001193125-26-009067 15212
2025-11-24 4 4 0001193125-25-293823 24503
2025-11-19 4 4 0001193125-25-288306 23907
2025-11-12 4 4 0001193125-25-277890 24335
2025-11-12 8-K 8-K 8.01 0001193125-25-277872 001-40767 251473989 34 145737 1 1
2025-11-04 4 4 0001193125-25-265046 22541
2025-10-23 8-K 8-K 1.01,2.03,9.01 0001193125-25-248883 001-40767 251413711 34 164742 1 1
2025-10-23 4 4 0001193125-25-248885 10569
2025-10-23 4 4 0001193125-25-248884 14004
2025-10-15 10-Q 10-Q 0001193125-25-240385 001-40767 251395528 34 11738434 1 1
2025-09-26 DEF 14A DEF 14A 0001193125-25-220757 001-40767 251351246 34 2066099
2025-09-26 ARS ARS 0001193125-25-220755 001-40767 251351245 34 572304
2025-09-18 4 4 0001193125-25-207528 25973
2025-09-10 4 4 0000950170-25-114029 31031
2025-09-10 8-K 8-K 8.01 0001193125-25-200170 001-40767 251306488 34 146487 1 1
2025-09-02 4 4 0000950170-25-112560 22314
2025-08-27 4 4 0000950170-25-111745 29870
2025-08-19 4 4 0000950170-25-110173 26293
2025-08-18 4 4 0000950170-25-109852 21212
2025-07-15 10-Q 10-Q 0000950170-25-095916 001-40767 251125450 34 11768111 1 1
2025-07-10 4 4 0000950170-25-095095 15367
2025-05-22 8-K 8-K 1.02 0000950170-25-076433 001-40767 25978046 34 147379 1 1
2025-05-08 8-K 8-K 8.01,9.01 0000950170-25-067147 001-40767 25927187 34 181981 1 1
2025-04-14 10-Q 10-Q 0000950170-25-053767 001-40767 25836631 34 10184081 1 1
2025-02-28 10-K 10-K 0000950170-25-030138 001-40767 25691861 34 14899328 1 1
2025-01-23 4 4 0000950170-25-008397 13584
2025-01-23 4 4 0000950170-25-008396 15275
2025-01-23 4 4 0000950170-25-008394 21217
2025-01-23 4 4 0000950170-25-008393 10843
2024-12-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-24-140872 005-80299 241586727 34 6543
2024-11-14 4 4 0000950170-24-127202 18146
2024-11-12 S-8 S-8 0001193125-24-256097 333-283174 241449906 33 78265
2024-10-31 4 4 0000950170-24-119672 14199
2024-10-31 8-K 8-K 5.07 0000950170-24-119642 001-40767 241416171 34 156402 1 1
2024-10-30 8-K 8-K 8.01,9.01 0000950170-24-118607 001-40767 241407598 34 202380 1 1
2024-10-17 10-Q/A 10-Q/A 0000950170-24-115377 001-40767 241378344 34 311369 1 1
2024-10-17 8-K 8-K 2.02,9.01 0000950170-24-115106 001-40767 241375560 34 190646 1 1
2024-10-15 10-Q 10-Q 0000950170-24-114762 001-40767 241372687 34 10533448 1 1
2024-10-07 ARS ARS 0001193125-24-233866 001-40767 241358473 34 7099936
2024-10-07 DEF 14A DEF 14A 0001193125-24-233861 001-40767 241358438 34 875101
2024-09-17 8-K 8-K 8.01 0000950170-24-107340 001-40767 241305139 34 145474 1 1
2024-07-15 10-Q 10-Q 0000950170-24-083637 001-40767 241117912 34 10882265 1 1
2024-04-15 10-Q 10-Q 0000950170-24-044493 001-40767 24845404 34 9831705 1 1
2024-03-26 8-K 8-K 7.01,9.01 0000950170-24-036165 001-40767 24781022 34 178108 1 1
2024-02-28 10-K 10-K 0000950170-24-022275 001-40767 24697055 34 13458672 1 1
2023-12-28 4 FORM 4 SUBMISSION 0001209191-23-059921 16080
2023-12-28 4 FORM 4 SUBMISSION 0001209191-23-059920 14981
2023-12-28 4 FORM 4 SUBMISSION 0001209191-23-059919 9832
2023-12-28 4 FORM 4 SUBMISSION 0001209191-23-059918 23047
2023-10-12 10-Q 10-Q 0000950170-23-053143 001-40767 231323297 34 12799030 1 1
2023-10-12 4 FORM 4 SUBMISSION 0001209191-23-052706 13121
2023-10-12 8-K 8-K 5.07 0000950170-23-053122 001-40767 231323055 34 167436 1 1
2023-09-15 ARS ARS 0000950170-23-048303 001-40767 231257210 34 462305
2023-09-14 DEF 14A DEF 14A 0001193125-23-235338 001-40767 231255450 34 275462
2023-08-25 8-K 8-K 8.01 0001193125-23-221510 001-40767 231208503 34 138331 1 1
2023-07-14 10-Q 10-Q 0000950170-23-033057 001-40767 231089766 34 13772560 1 1
2023-04-21 10-Q 10-Q 0000950170-23-013868 001-40767 23836811 34 12038339 1 1
2023-04-14 NT 10-Q NT 10-Q 0001193125-23-102239 001-40767 23821910 34 20604
2023-03-09 8-K 8-K 1.01,9.01 0000950170-23-007079 001-40767 23720613 34 173945 1 1
2023-02-28 10-K 10-K 0000950170-23-005220 001-40767 23687614 34 16635942 1 1
2023-02-14 SC 13G/A cryo13ga5-021423.htm 0001013594-23-000248 005-80299 23629445 34 89246
2023-02-03 RW RW 0001193125-23-024302 333-264108 23586985 NE 6157
2023-01-17 4 FORM 4 SUBMISSION 0001209191-23-003547 8321
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002381 15774
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002380 22741
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001973 21234
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001972 14267
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001953 13826
2022-12-29 8-K 8-K 5.02,9.01 0000950170-22-027095 001-40767 221499404 34 534745 1 1
2022-11-21 4 FORM 4 SUBMISSION 0001209191-22-058194 23092
2022-11-15 4 FORM 4 SUBMISSION 0001209191-22-057065 33314
2022-11-10 4 FORM 4 SUBMISSION 0001209191-22-056434 33038
2022-10-18 10-Q 10-Q 0000950170-22-019626 001-40767 221314716 34 16478075 1 1
2022-10-18 NT 10-Q NT 10-Q 0000950170-22-019624 001-40767 221314669 34 66986
2022-10-05 8-K 8-K 5.07 0000950170-22-019317 001-40767 221296316 34 183674 1 1
2022-10-05 4 FORM 4 SUBMISSION 0001209191-22-052800 12039
2022-09-16 DEF 14A DEF 14A 0001193125-22-246473 001-40767 221248663 34 741658
2022-09-01 4 FORM 4 SUBMISSION 0001209191-22-048264 20349
2022-08-30 25 25 0001193125-22-233208 001-40767 221212685 34 15636
2022-08-29 4 FORM 4 SUBMISSION 0001209191-22-047884 13463
2022-08-29 4 FORM 4 SUBMISSION 0001209191-22-047883 23675
2022-08-29 4 FORM 4 SUBMISSION 0001209191-22-047881 15042
2022-08-29 CERT NYSE AMERICAN CERTIFICATION 0000876661-22-000717 001-40767 221208440 34 640640
2022-08-29 8-A12B FORM 8-A12B 0001193125-22-231971 001-40767 221207340 34 22990
2022-08-23 8-K 8-K 8.01 0000950170-22-017696 001-40767 221188183 34 163485 1 1
2022-08-23 8-K 8-K 8.01 0000950170-22-017659 001-40767 221184696 34 161552 1 1
2022-07-22 8-K 8-K 1.01,2.03 0000950170-22-012926 001-40767 221100258 34 174561 1 1
2022-07-11 10-Q 10-Q 0000950170-22-012605 001-40767 221077477 34 11640555 1 1
2022-04-28 S-1/A S-1/A 0001193125-22-124542 333-264108 22861747 33 1321207
2022-04-27 10-Q/A 10-Q/A 0000950170-22-006286 001-40767 22856675 34 352841 1 1
2022-04-14 4/A FORM 4/A SUBMISSION 0001209191-22-024406 31871
2022-04-14 4/A FORM 4/A SUBMISSION 0001209191-22-024405 19812
2022-04-13 10-Q 10-Q 0000950170-22-005662 001-40767 22825016 34 11125504 1 1
2022-04-04 S-1 S-1 0001193125-22-095092 333-264108 22802318 33 1498229
2022-03-16 8-K 8-K 1.01,8.01,9.01 0000950170-22-003951 001-40767 22745621 34 1310487 1 1
2022-02-24 8-K 8-K 2.02,9.01 0000950170-22-002003 001-40767 22672188 34 197326 1 1
2022-02-22 10-K 10-K 0000950170-22-001637 001-40767 22659168 34 14924383 1 1
2022-02-14 SC 13G/A cryo13ga4-020421.htm 0001013594-22-000219 005-80299 22628274 34 89453
2022-02-08 4/A FORM 4/A SUBMISSION 0001209191-22-007783 15221
2022-02-08 4/A FORM 4/A SUBMISSION 0001209191-22-007782 25376
2022-01-25 8-K 8-K 3.01 0000950170-22-000481 001-40767 22554651 34 158578 1 1
2021-12-29 4 FORM 4 SUBMISSION 0001209191-21-071484 12508
2021-12-28 4 FORM 4 SUBMISSION 0001209191-21-071380 12623
2021-12-27 4 FORM 4 SUBMISSION 0001209191-21-071279 14863
2021-12-27 4 FORM 4 SUBMISSION 0001209191-21-071278 22218
2021-12-15 8-K 8-K 5.02 0001564590-21-060452 001-40767 211495092 34 164199 1 1
2021-10-25 8-K 8-K 5.07 0001564590-21-051764 001-40767 211345087 34 193461 1 1
2021-10-21 4 FORM 4 SUBMISSION 0001209191-21-061275 14448
2021-10-21 4 FORM 4 SUBMISSION 0001209191-21-061273 10163
2021-10-15 10-Q 10-Q 0001564590-21-050960 001-40767 211326584 34 12889772 1 1
2021-10-15 8-K 8-K 2.02,9.01 0001564590-21-050957 001-40767 211326470 34 192694 1 1
2021-10-01 DEF 14A DEF 14A 0001193125-21-289831 001-40767 211299764 34 955915
2021-09-22 8-K 8-K 5.02,8.01,9.01 0001564590-21-048617 001-40767 211270364 34 213152 1 1
2021-09-21 4 FORM 4 SUBMISSION 0001209191-21-057052 14499
2021-09-15 4 FORM 4 SUBMISSION 0001209191-21-056189 22387
2021-09-01 4 FORM 4 SUBMISSION 0001209191-21-054280 25331
2021-08-30 CERT 8A_Cert_CCEL.pdf 0001354457-21-000988 001-40767 211223216 34 249065
2021-08-27 8-A12B 8-A12B 0001193125-21-259445 001-40767 211219912 34 21786
2021-08-26 4 FORM 4 SUBMISSION 0001209191-21-053499 15073
2021-08-26 4 FORM 4 SUBMISSION 0001209191-21-053500 22421
2021-08-04 8-K 8-K 5.02,9.01 0001564590-21-040910 000-23386 211144976 34 318823 1 1
2021-07-26 4 FORM 4 SUBMISSION 0001209191-21-048202 19724
2021-07-20 4 FORM 4 SUBMISSION 0001209191-21-047409 19725
2021-07-19 8-K 8-K 2.02,9.01 0001564590-21-037044 000-23386 211098491 34 191082 1 1
2021-07-15 10-Q 10-Q 0001564590-21-036760 000-23386 211093458 34 12630044 1 1
2021-06-30 8-K 8-K 5.02,9.01 0001564590-21-035363 000-23386 211062648 34 277901
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036311 19723
2021-05-26 4 FORM 4 SUBMISSION 0001209191-21-035964 24366
2021-05-26 4 FORM 4 SUBMISSION 0001209191-21-035965 17019
2021-05-25 4 FORM 4 SUBMISSION 0001209191-21-035737 21462
2021-05-18 4 FORM 4 SUBMISSION 0001209191-21-033857 21462
2021-05-12 4 FORM 4 SUBMISSION 0001209191-21-032094 25462
2021-05-05 4 FORM 4 SUBMISSION 0001209191-21-030364 23369
2021-04-28 4 FORM 4 SUBMISSION 0001209191-21-028820 25595
2021-04-26 4 FORM 4 SUBMISSION 0001209191-21-028303 23369
2021-04-20 4 FORM 4 SUBMISSION 0001209191-21-027579 22418
2021-04-16 8-K 8-K 2.02,9.01 0001564590-21-019173 000-23386 21831439 34 50890
2021-04-14 10-Q 10-Q 0001564590-21-018845 000-23386 21826476 34 9054694 1
2021-03-10 4 FORM 4 SUBMISSION 0001209191-21-019527 16201
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018297 16200
2021-03-01 10-K 10-K 0001564590-21-009945 000-23386 21699475 34 12768429 1
2021-02-25 8-K 8-K 2.02,9.01 0001564590-21-008966 000-23386 21681856 34 46298
2021-02-16 SC 13G/A cryo13ga3-021621.htm 0001013594-21-000171 005-80299 21637100 34 82239
2021-01-26 4 FORM 4 SUBMISSION 0001209191-21-005388 21461
2021-01-20 4 FORM 4 SUBMISSION 0001209191-21-004307 27557
2021-01-15 4 FORM 4 SUBMISSION 0001209191-21-003742 26456
2021-01-12 4 FORM 4 SUBMISSION 0001209191-21-003256 21885
2021-01-06 4 FORM 4 SUBMISSION 0001209191-21-002210 24931
2020-12-10 8-K 8-K 1.01 0001564590-20-056747 000-23386 201381289 34 32745
2020-11-18 4 FORM 4 SUBMISSION 0001209191-20-059112 21886
2020-11-13 4 FORM 4 SUBMISSION 0001209191-20-058324 26454
2020-11-10 4 FORM 4 SUBMISSION 0001209191-20-057690 26003
2020-11-09 4 FORM 4 SUBMISSION 0001209191-20-057523 13854
2020-11-05 4 FORM 4 SUBMISSION 0001209191-20-057218 31411
2020-11-02 4 FORM 4 SUBMISSION 0001209191-20-056425 33623
2020-10-26 4 FORM 4 SUBMISSION 0001209191-20-055824 34687
2020-10-21 4 FORM 4 SUBMISSION 0001209191-20-055486 21886
2020-10-19 8-K 8-K 2.02,9.01 0001564590-20-046773 000-23386 201246294 34 43367
2020-10-15 10-Q 10-Q 0001564590-20-046540 000-23386 201242004 34 11495544 1
2020-09-25 4 FORM 4 SUBMISSION 0001209191-20-052134 7001
2020-09-25 4 FORM 4 SUBMISSION 0001209191-20-052131 11099
2020-09-24 4 FORM 4 SUBMISSION 0001209191-20-051880 13854
2020-09-24 4 FORM 4 SUBMISSION 0001209191-20-051877 8804
2020-09-24 4 FORM 4 SUBMISSION 0001209191-20-051876 14678
2020-09-24 4 FORM 4 SUBMISSION 0001209191-20-051874 8160
2020-09-24 4 FORM 4 SUBMISSION 0001209191-20-051871 14000
2020-09-23 8-K 8-K 5.07 0001193125-20-252410 000-23386 201192706 34 28313
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-050976 8245
2020-09-10 UPLOAD filename1.pdf 0000000000-20-008542 39732
2020-09-08 8-K 8-K 1.01,1.02 0001193125-20-241086 000-23386 201164732 34 18230
2020-09-08 CORRESP filename1.htm 0001193125-20-241005 44799
2020-09-01 DEF 14A DEF 14A 0001193125-20-237275 000-23386 201154947 34 274874
2020-08-14 4 FORM 4 SUBMISSION 0001209191-20-046824 19873
2020-08-11 8-K 8-K 5.08 0001193125-20-216447 000-23386 201093201 34 18540
2020-08-10 4 FORM 4 SUBMISSION 0001209191-20-045987 7825
2020-08-10 4 FORM 4 SUBMISSION 0001209191-20-045982 26118
2020-08-07 4 FORM 4 SUBMISSION 0001209191-20-045670 7825
2020-08-06 4 FORM 4 SUBMISSION 0001209191-20-045524 35615
2020-08-03 4 FORM 4 SUBMISSION 0001209191-20-044520 29393
2020-08-03 4 FORM 4 SUBMISSION 0001209191-20-044482 14961
2020-07-28 4 FORM 4 SUBMISSION 0000899243-20-020559 15079
2020-07-28 4 FORM 4 SUBMISSION 0000899243-20-020557 13328
2020-07-28 4 FORM 4 SUBMISSION 0000899243-20-020516 24823
2020-07-24 4 FORM 4 SUBMISSION 0000899243-20-020410 35928
2020-07-20 4 FORM 4 SUBMISSION 0000899243-20-019697 17401
2020-07-15 4 FORM 4 SUBMISSION 0000899243-20-019195 14008
2020-07-15 4 FORM 4 SUBMISSION 0000899243-20-019190 15125
2020-07-13 8-K 8-K 2.02,9.01 0001193125-20-191942 000-23386 201025708 34 29394
2020-07-13 UPLOAD filename1.pdf 0000000000-20-006287 45733
2020-07-10 10-Q 10-Q 0001193125-20-191169 000-23386 201023790 34 6615153 1
2020-06-16 4 FORM 4 SUBMISSION 0000899243-20-016676 17217
2020-06-16 4 FORM 4 SUBMISSION 0000899243-20-016675 40765
2020-06-16 4 FORM 4 SUBMISSION 0000899243-20-016673 35423
2020-06-16 4 FORM 4 SUBMISSION 0000899243-20-016672 12653
2020-06-11 8-K 8-K 1.01,9.01 0001193125-20-166773 000-23386 20958020 34 122904
2020-06-08 4 FORM 4 SUBMISSION 0000899243-20-015642 000-50746 20950052 34 12067
2020-06-02 4 FORM 4 SUBMISSION 0000899243-20-014923 000-50746 20937936 34 12067
2020-05-14 4 FORM 4 SUBMISSION 0000899243-20-013070 000-50746 20877602 34 15142
2020-05-06 8-K 8-K 2.02,9.01 0001193125-20-135019 000-23386 20853458 34 25616
2020-05-06 4 FORM 4 SUBMISSION 0000899243-20-012129 000-50746 20852497 34 15103
2020-05-04 4 FORM 4 SUBMISSION 0000899243-20-011914 25851
2020-05-04 4 FORM 4 SUBMISSION 0000899243-20-011907 000-50746 20846042 34 13495
2020-04-30 4 FORM 4 SUBMISSION 0000899243-20-011648 000-50746 20836185 34 13493
2020-04-14 10-Q 10-Q 0001193125-20-107163 000-23386 20791792 34 6014644 1
2020-03-02 4 FORM 4 SUBMISSION 0000899243-20-006534 14259
2020-03-02 8-K 8-K 2.02,9.01 0001193125-20-058853 000-23386 20676699 34 28030
2020-02-28 10-K 10-K 0001193125-20-056695 000-23386 20671434 34 9660396 1
2020-02-21 4 FORM 4 SUBMISSION 0000899243-20-005499 000-50746 20641294 34 13497
2020-02-14 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0001013594-20-000166 005-80299 20616129 34 97684
2020-02-13 4 FORM 4 SUBMISSION 0000899243-20-004587 000-50746 20613442 34 16149
2020-02-05 4 FORM 4 SUBMISSION 0000899243-20-003258 000-50746 20578915 34 11840
2020-02-03 4 FORM 4 SUBMISSION 0000899243-20-002534 000-50746 20568498 34 13496
2020-01-30 4 FORM 4 SUBMISSION 0000899243-20-002365 000-50746 20562683 34 11840
2020-01-13 4 FORM 4 SUBMISSION 0000899243-20-001060 14081
2020-01-07 4 FORM 4 SUBMISSION 0000899243-20-000718 000-50746 20513466 34 13341
2019-12-26 4 FORM 4 SUBMISSION 0000899243-19-030056 14125
2019-12-26 4 FORM 4 SUBMISSION 0000899243-19-030052 19079
2019-12-13 4 FORM 4 SUBMISSION 0000899243-19-029115 8564
2019-12-12 4 FORM 4 SUBMISSION 0000899243-19-029063 17242
2019-12-12 4 FORM 4 SUBMISSION 0000899243-19-029062 17237
2019-12-12 4 FORM 4 SUBMISSION 0000899243-19-029061 7779
2019-12-12 4 FORM 4 SUBMISSION 0000899243-19-029057 17915
2019-11-27 8-K 8-K 5.07 0001193125-19-302703 000-23386 191258880 34 52414
2019-11-25 4 FORM 4 SUBMISSION 0000899243-19-028076 16030
2019-11-25 4 FORM 4 SUBMISSION 0000899243-19-028074 21940
2019-11-19 4 FORM 4 SUBMISSION 0000899243-19-027593 000-50746 191232137 34 14893
2019-10-29 DEF 14A DEF 14A 0001193125-19-277935 000-23386 191176819 34 789245
2019-10-17 8-K 8-K 2.02,9.01 0001193125-19-269300 000-23386 191155172 34 28981
2019-10-15 10-Q 10-Q 0001193125-19-267766 000-23386 191151512 34 7508831 1
2019-10-11 PRE 14A PRE 14A 0001193125-19-266832 000-23386 191148572 34 800303
2019-10-09 8-K 8-K 8.01 0001193125-19-264637 000-23386 191143624 34 17650
2019-10-02 8-K 8-K 4.01,9.01 0001193125-19-260827 000-23386 191133042 34 20261
2019-09-20 4 FORM 4 SUBMISSION 0000899243-19-023993 13615
2019-09-04 4 FORM 4 SUBMISSION 0000899243-19-022754 10862
2019-09-04 4 FORM 4 SUBMISSION 0000899243-19-022752 14636
2019-09-04 4 FORM 4 SUBMISSION 0000899243-19-022751 12659
2019-09-04 4 FORM 4 SUBMISSION 0000899243-19-022750 7207
2019-09-04 4 FORM 4 SUBMISSION 0000899243-19-022749 17613
2019-09-04 4 FORM 4 SUBMISSION 0000899243-19-022748 6421
2019-09-04 4 FORM 4 SUBMISSION 0000899243-19-022747 13957
2019-09-04 4 FORM 4 SUBMISSION 0000899243-19-022746 14918
2019-07-25 8-K 8-K 2.02,9.01 0001193125-19-202614 000-23386 19975103 34 29030
2019-07-15 10-Q FORM 10-Q 0001193125-19-194098 000-23386 19955737 34 11266282 1
2019-05-02 4 FORM 4 SUBMISSION 0000899243-19-011805 14960
2019-04-24 4 FORM 4 SUBMISSION 0000899243-19-011038 5816
2019-04-16 8-K 8-K 2.02,9.01 0001193125-19-107922 000-23386 19751512 34 29500
2019-04-15 10-Q 10-Q 0001193125-19-106727 000-23386 19749290 34 5194626 1
2019-03-01 8-K 8-K 2.02,9.01 0001193125-19-061140 000-23386 19650158 34 26935
2019-02-28 10-K 10-K 0001193125-19-057945 000-23386 19644879 34 7000645 1
2019-02-14 SC 13G/A FEBRUARY 14, 2019 0001013594-19-000174 005-80299 19603211 34 110079
2019-02-11 4 FORM 4 SUBMISSION 0000899243-19-003171 5037
2019-02-04 4 FORM 4 SUBMISSION 0000899243-19-002469 19888
2019-01-11 4 FORM 4 SUBMISSION 0000899243-19-001008 5036
2018-12-11 8-K FORM 8-K 5.03,9.01 0001193125-18-347078 000-23386 181229530 34 108390
2018-11-13 4 FORM 4 SUBMISSION 0000899243-18-028708 5037
2018-10-23 4 FORM 4 SUBMISSION 0000899243-18-027298 5818
2018-10-22 8-K 8-K 2.02,9.01 0001193125-18-304332 000-23386 181132814 34 28195
2018-10-19 4 FORM 4 SUBMISSION 0000899243-18-027088 5038
2018-10-15 10-Q FORM 10-Q 0001193125-18-299303 000-23386 181122763 34 4960417 1
2018-09-04 4 FORM 4 SUBMISSION 0000899243-18-023732 15646
2018-09-04 4 FORM 4 SUBMISSION 0000899243-18-023731 7341
2018-08-30 8-K/A FORM 8-K/A 9.01 0001193125-18-263786 000-23386 181047989 34 573655
2018-08-30 4 FORM 4 SUBMISSION 0000899243-18-023562 15636
2018-08-29 4 FORM 4 SUBMISSION 0000899243-18-023487 14956
2018-08-27 4 FORM 4 SUBMISSION 0000899243-18-023300 5816
2018-08-22 4 FORM 4 SUBMISSION 0000899243-18-023026 15069
2018-08-22 4 FORM 4 SUBMISSION 0000899243-18-023025 7340
2018-08-17 4 FORM 4 SUBMISSION 0000899243-18-022695 000-50746 181025775 34 11668
2018-08-17 4 FORM 4 SUBMISSION 0000899243-18-022694 16275
2018-08-16 3 FORM 3 SUBMISSION 0000899243-18-022569 4074
2018-08-16 3 FORM 3 SUBMISSION 0000899243-18-022568 4855
2018-08-16 8-K FORM 8-K 1.02,5.02,5.07,9.01 0001193125-18-250669 000-23386 181023500 34 87483
2018-08-15 4 FORM 4 SUBMISSION 0000899243-18-022519 21191
2018-08-14 4 FORM 4 SUBMISSION 0000899243-18-022308 14961
2018-07-26 DEF 14A DEF 14A 0001193125-18-227909 000-23386 18972391 34 264581
2018-07-17 8-K 8-K 2.02,9.01 0001193125-18-219667 000-23386 18956538 34 24376
2018-07-16 10-Q 10-Q 0001193125-18-218864 000-23386 18955053 34 3897689 1
2018-06-21 SC 13G SC 13G 0001193125-18-199122 005-80299 18911427 34 31654
2018-06-15 8-K FORM 8-K 1.01,2.01,3.02,9.01 0001193125-18-194459 000-23386 18902190 34 126140
2018-06-04 8-K FORM 8-K 1.01,3.02,9.01 0001193125-18-182606 000-23386 18877003 34 389536
2018-05-24 8-K 8-K 5.02,9.01 0001193125-18-173552 000-23386 18857877 34 47411
2018-05-22 4 FORM 4 SUBMISSION 0000899243-18-013683 8530
2018-04-18 8-K 8-K 2.02,9.01 0001193125-18-121029 000-23386 18761242 34 25858
2018-04-16 10-Q 10-Q 0001193125-18-118744 000-23386 18757374 34 3234475 1
2018-03-20 4 FORM 4 SUBMISSION 0000899243-18-008133 11511
2018-03-20 4 FORM 4 SUBMISSION 0000899243-18-008132 16474
2018-03-14 4 FORM 4 SUBMISSION 0000899243-18-007381 11318
2018-03-14 4 FORM 4 SUBMISSION 0000899243-18-007380 16281
2018-03-13 8-K 8-K 5.02,8.01,9.01 0001193125-18-080398 000-23386 18685796 34 298976
2018-03-01 8-K 8-K 2.02,9.01 0001193125-18-067305 000-23386 18657882 34 25870
2018-02-28 10-K 10-K 0001193125-18-064199 000-23386 18652201 34 6218046 1
2018-02-26 4 FORM 4 SUBMISSION 0000899243-18-005508 000-50746 18641857 34 14713
2018-02-23 4 FORM 4 SUBMISSION 0000899243-18-005292 15158
2018-02-21 3 FORM 3 SUBMISSION 0000899243-18-004831 000-50746 18629417 34 10522
2018-02-15 SC 13D/A SC 13D/A 0001193125-18-047423 117647
2018-02-14 SC 13G FEBRUARY 14, 2018 0001013594-18-000152 005-80299 18613440 34 95027
2018-01-23 4 FORM 4 SUBMISSION 0000899243-18-001673 15004
2018-01-19 SC 13G/A SC 13G AMENDMENT NO. 4 0001193125-18-013554 005-80299 18534991 34 31999
2017-12-29 4 FORM 4 SUBMISSION 0000899243-17-029724 11669
2017-10-17 8-K FORM 8-K 2.02,9.01 0001193125-17-311911 000-23386 171141263 34 25895
2017-10-17 8-K FORM 8-K 2.02,9.01 0001193125-17-311905 000-23386 171141233 34 27039
2017-10-16 10-Q 10-Q 0001193125-17-310883 000-23386 171138744 34 4320299 1
2017-08-29 4 FORM 4 SUBMISSION 0000899243-17-021182 14110
2017-08-29 4 FORM 4 SUBMISSION 0000899243-17-021181 14117
2017-08-29 4 FORM 4 SUBMISSION 0000899243-17-021180 14007
2017-08-14 4 FORM 4 SUBMISSION 0000899243-17-020230 6828
2017-08-14 3 FORM 3 SUBMISSION 0000899243-17-020229 5498
2017-07-26 4 FORM 4 SUBMISSION 0000899243-17-019038 15840
2017-07-18 8-K FORM 8-K 5.07 0001193125-17-230411 000-23386 17970140 34 31967
2017-07-07 10-Q FORM 10-Q 0001193125-17-224319 000-23386 17955804 34 4163258 1
2017-06-26 DEF 14A DEFINITIVE PROXY STATEMENT 0001193125-17-213395 000-23386 17930449 34 268501
2017-05-23 4 FORM 4 SUBMISSION 0000899243-17-014136 10937
2017-04-17 8-K FORM 8-K 2.02,9.01 0001193125-17-125401 000-23386 17763851 34 24810
2017-04-13 10-Q FORM 10-Q 0001193125-17-123411 000-23386 17761485 34 3913046 1
2017-03-07 4 FORM 4 SUBMISSION 0000899243-17-006701 8695
2017-03-06 8-K FORM 8-K 2.02,9.01 0001193125-17-071853 000-23386 17668888 34 23712
2017-02-28 10-K FORM 10-K 0001193125-17-062739 000-23386 17649499 34 6959038 1
2017-02-15 4 FORM 4 SUBMISSION 0000899243-17-004223 15820
2017-02-15 4 FORM 4 SUBMISSION 0000899243-17-004220 10176
2017-02-14 SC 13G/A SCHEDULE 13G AMENDMENT NO. 3 0001193125-17-042741 005-80299 17606288 34 29798
2017-02-06 4 FORM 4 SUBMISSION 0000899243-17-002847 8897
2016-12-14 4 FORM 4 SUBMISSION 0000899243-16-035557 15701
2016-11-03 8-K FORM 8-K 1.02,9.01 0001193125-16-759073 000-23386 161972814 34 24729
2016-10-17 10-Q FORM 10-Q 0001193125-16-739879 000-23386 161939480 34 4617936 1
2016-10-13 8-K FORM 8-K 8.01,9.01 0001193125-16-737745 000-23386 161935392 34 14528
2016-08-30 8-K FORM 8-K 8.01,9.01 0001193125-16-696964 000-23386 161861213 34 14760
2016-08-17 4 FORM 4 SUBMISSION 0000899243-16-027453 10100
2016-08-01 8-K FORM 8-K 8.01,9.01 0001193125-16-666311 000-23386 161796846 34 14893
2016-07-12 8-K FORM 8-K 2.02,9.01 0001193125-16-646390 000-23386 161764247 34 24863
2016-07-11 10-Q FORM 10-Q 0001193125-16-645605 000-23386 161762775 34 4375106 1
2016-07-07 8-K FORM 8-K 5.07 0001193125-16-643449 000-23386 161756808 34 27441
2016-07-07 4 FORM 4 SUBMISSION 0000899243-16-024722 12763
2016-07-07 4 FORM 4 SUBMISSION 0000899243-16-024720 12756
2016-07-07 4 FORM 4 SUBMISSION 0000899243-16-024719 12652
2016-07-01 8-K FORM 8-K 8.01 0001193125-16-640607 000-23386 161747686 34 12347
2016-06-24 8-K FORM 8-K 1.01,9.01 0001193125-16-631702 000-23386 161731833 34 71943
2016-06-21 DEF 14A DEFINITIVE PROXY STATEMENT 0001193125-16-627902 000-23386 161724945 34 263504
2016-05-26 8-K FORM 8-K 2.03,5.03,9.01 0001193125-16-604450 000-23386 161679013 34 98618
2016-04-20 4 FORM 4 SUBMISSION 0000899243-16-018348 9983
2016-04-20 4 FORM 4 SUBMISSION 0000899243-16-018347 8108
2016-04-20 8-K FORM 8-K 5.02,9.01 0001193125-16-548359 000-23386 161581786 34 43214
2016-04-20 4 FORM 4 SUBMISSION 0000899243-16-018343 15640
2016-04-19 8-K FORM 8-K 5.02,9.01 0001193125-16-546715 000-23386 161579822 34 197105
2016-04-14 8-K FORM 8-K 2.02,9.01 0001193125-16-541627 000-23386 161572503 34 23997 1
2016-04-14 10-Q FORM 10-Q 0001193125-16-541409 000-23386 161571830 34 3909882 1
2016-04-13 SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 0001193125-16-538790 75617
2016-03-18 8-K FORM 8-K 4.01,9.01 0001193125-16-510540 000-23386 161517003 34 18936
2016-03-18 8-K FORM 8-K 5.03,9.01 0001193125-16-510527 000-23386 161516944 34 97881
2016-03-14 8-K FORM 8-K 5.03,9.01 0001193125-16-503638 000-23386 161504572 34 98364
2016-03-02 8-K FORM 8-K 2.02,9.01 0001193125-16-490195 000-23386 161477971 34 23045
2016-02-29 10-K FORM 10-K 0001193125-16-485790 000-23386 161469948 34 6610077 1
2016-02-02 4 FORM 4 SUBMISSION 0000899243-16-012550 14463
2016-02-02 4 FORM 4 SUBMISSION 0000899243-16-012549 8805
2015-10-15 10-Q FORM 10-Q 0001193125-15-344846 000-23386 151160675 34 4130270 1
2015-09-24 4 FORM 4 SUBMISSION 0000899243-15-005334 9565
2015-08-14 4 FORM 4 SUBMISSION 0000899243-15-003153 14801
2015-07-30 SC TO-I/A AMENDMENT NO.1 TO SCHEDULE TO 0001193125-15-270573 005-80299 151015822 34 28538
2015-07-17 8-K FORM 8-K 2.02,9.01 0001193125-15-255972 000-23386 15993837 34 24171
2015-07-16 8-K FORM 8-K 1.01,9.01 0001193125-15-254853 000-23386 15991679 34 29019
2015-07-15 10-Q FORM 10-Q 0001193125-15-253772 000-23386 15989998 34 3053149 1
2015-07-13 4 FORM 4 SUBMISSION 0000899243-15-001145 12356
2015-07-13 4 FORM 4 SUBMISSION 0000899243-15-001144 6728
2015-07-13 4 FORM 4 SUBMISSION 0000899243-15-001142 12363
2015-07-13 4 FORM 4 SUBMISSION 0000899243-15-001141 12253
2015-07-13 8-K FORM 8-K 5.07,9.01 0001193125-15-251009 000-23386 15985207 34 26916
2015-06-30 SC TO-I SCHEDULE TO 0001193125-15-241079 005-80299 15961193 34 752732
2015-06-19 8-K FORM 8K 1.01,9.01 0001193125-15-228991 000-23386 15942987 34 161107
2015-06-16 DEF 14A DEFINITIVE PROXY STATEMENT 0001193125-15-224773 000-23386 15934973 34 263619
2015-05-14 SC 13D/A SCHEDULE 13D AMEND NO 1 0001193125-15-188291 42325
2015-05-11 4 xslF345X03/rrd424886.xml 0001181431-15-006717 17108
2015-04-15 8-K FORM 8-K 2.02,9.01 0001193125-15-131518 000-23386 15772682 34 24424
2015-04-14 10-Q FORM 10-Q 0001193125-15-129576 000-23386 15769945 34 3642827 1
2015-04-13 8-K FORM 8-K 8.01,9.01 0001193125-15-127719 000-23386 15767371 34 14726
2015-04-08 4 xslF345X03/rrd424223.xml 0001181431-15-005692 14052
2015-04-02 4/A FORM 4/A 0001140361-15-014186 17127
2015-04-02 8-K FORM 8-K 8.01,9.01 0001193125-15-116421 000-23386 15744801 34 20704
2015-03-31 4 xslF345X03/rrd423992.xml 0001181431-15-005281 17007
2015-03-20 SC 13D FORM 13D 0000943374-15-000178 84433
2015-03-10 8-K FORM 8-K LAWSUIT 8.01,9.01 0000943374-15-000169 000-23386 15690138 34 27859
2015-03-09 4 xslF345X03/rrd423453.xml 0001181431-15-004384 17117
2015-03-04 8-K 8-K 2.02,9.01 0001193125-15-077042 000-23386 15674541 34 24256

Latest XBRL company facts

One latest value per concept from companyfacts (409 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 8.06M 2026-10-08 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
dei EntityPublicFloat Entity Public Float USD 26.52M 2025-05-31 2025 FY 10-K 2026-02-27 0001193125-26-083096
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 320,338 2024-12-01 2025-11-30 DEF 14A 2026-10-13 0001193125-26-420608
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 373,132 2024-12-01 2025-11-30 DEF 14A 2026-10-13 0001193125-26-420608
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 107.78 2024-12-01 2025-11-30 DEF 14A 2026-10-13 0001193125-26-420608
srt StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased shares 8.00M 2016-10-06 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AccountsAndNotesReceivableNet Accounts and Financing Receivable, after Allowance for Credit Loss USD 0 2014-11-30 2014 FY 10-K 2015-03-02 0001193125-15-073665
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.42M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 608,833 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 6.83M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 950,000 2007-07-16 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 959,904 2020-11-30 2020 FY 10-K 2021-03-01 0001564590-21-009945
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.57M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 2.06M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 219,951 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap AccumulatedAmortizationOfCurrentDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs, Current USD 32,289 2017-05-31 2017 Q2 10-Q 2017-07-07 0001193125-17-224319
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 6.56M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 340,984 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 27.68M 2014-08-31 2014 Q3 10-Q 2014-10-15 0001193125-14-372812
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 45.05M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AdjustmentForAmortization Amortization USD 208,300 2018-12-01 2019-05-31 2019 Q2 10-Q 2019-07-15 0001193125-19-194098
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 315,967 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AdvertisingExpense Advertising Expense USD 1.09M 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 315,967 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 1.37M 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap AllowanceForDoubtfulAccountsReceivableChargeOffs Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) USD 434,401 2011-12-01 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 4.37M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 347,699 2023-12-01 2024-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 1.17M 2023-12-01 2024-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 15,326 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 33,000 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.03M 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap AreaOfLand Area of Land sqft 8,800 2022-06-10 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 627,034 2010-12-01 2011-11-30 2011 FY 10-K 2012-02-28 0001193125-12-085810
us-gaap Assets Assets USD 62.30M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AssetsCurrent Assets, Current USD 13.17M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 226,276 2014-12-01 2015-05-31 2015 Q2 10-Q 2015-07-15 0001193125-15-253772
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares 0.36 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap BusinessAcquisitionProFormaEarningsPerShareDiluted Business Acquisition, Pro Forma Earnings Per Share, Diluted USD/shares 0.36 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD 2.66M 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 31.39M 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 2,794 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 47,020 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 423,504 2014-12-01 2015-11-30 2016 FY 10-K 2017-02-28 0001193125-17-062739
us-gaap CapitalizedContractCostAccumulatedAmortization Capitalized Contract Cost, Accumulated Amortization USD 66,533 2018-12-01 2020 FY 10-K 2021-03-01 0001564590-21-009945
us-gaap CapitalizedContractCostNet Capitalized Contract Cost, Net USD 329,231 2018-12-01 2020 FY 10-K 2021-03-01 0001564590-21-009945
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.43M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 428,554 2018-12-01 2019-05-31 2019 Q2 10-Q 2019-07-15 0001193125-19-194098
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.43M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 1.11M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CashCollateralForBorrowedSecurities Cash Collateral for Borrowed Securities USD 200,000 2015-11-30 2016 FY 10-K 2017-02-28 0001193125-17-062739
us-gaap CertificatesOfDepositAtCarryingValue Certificates of Deposit, at Carrying Value USD 204,000 2016-11-30 2016 FY 10-K 2017-02-28 0001193125-17-062739
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.50M 2022-04-08 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0.25 2024-12-01 2025-02-28 2025 Q1 10-Q 2025-04-14 0000950170-25-053767
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 20.00M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 14.88M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 8.06M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CommonStockValue Common Stock, Value, Issued USD 148,846 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 2.29M 2018-12-01 2019-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 909,108 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ContractWithCustomerAssetPurchase Contract with Customer, Asset, Purchase USD 11.20M 2022-03-14 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 63.97M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 9.72M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 54.25M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 4.95M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CostOfGoodsAndServicesSoldDepreciation Cost, Depreciation USD 134,000 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap CostOfServices Cost of Services (Deprecated 2018-01-31) USD 3.38M 2017-12-01 2018-05-31 2018 Q2 10-Q 2018-07-16 0001193125-18-218864
us-gaap CostsAndExpenses Costs and Expenses USD 19.13M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD -340,984 2019-05-31 2020 Q2 10-Q 2020-07-10 0001193125-20-191169
us-gaap CumulativeEffectOnRetainedEarningsNetOfTax1 Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) USD 253,447 2018-12-01 2019-05-31 2020 Q2 10-Q 2020-07-10 0001193125-20-191169
us-gaap CumulativeEffectOnRetainedEarningsTax1 Cumulative Effect on Retained Earnings, Tax (Deprecated 2020-01-31) USD 94,192 2018-12-01 2019-05-31 2020 Q2 10-Q 2020-07-10 0001193125-20-191169
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 2.13M 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 2.91M 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 780,000 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 112,019 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees Debtor Reorganization Items, Legal and Advisory Professional Fees USD 81,250 2011-12-01 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense USD 700,000 2011-12-01 2012-08-31 2013 Q3 10-Q 2013-10-15 0001193125-13-400021
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -2.26M 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 32,289 2017-05-31 2017 Q2 10-Q 2017-07-07 0001193125-17-224319
us-gaap DeferredFinanceCostsNoncurrentGross Debt Issuance Cost, Gross, Noncurrent USD 548,085 2023-02-28 2023 Q1 10-Q 2023-04-21 0000950170-23-013868
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 23.62M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD -2.82M 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -2.82M 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.43M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredRevenue Deferred Revenue USD 0 2014-11-30 2014 FY 10-K 2015-03-02 0001193125-15-073665
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 8.37M 2018-11-30 2018 FY 10-K 2019-02-28 0001193125-19-057945
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 20.32M 2018-11-30 2018 FY 10-K 2019-02-28 0001193125-19-057945
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -562,000 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 14.77M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 26.55M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 466,000 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 105,000 2023-11-30 2023 FY 10-K 2024-02-28 0000950170-24-022275
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 23.62M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 1.34M 2015-11-30 2016 FY 10-K 2017-02-28 0001193125-17-062739
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 9.08M 2020-02-29 2020 Q1 10-Q 2020-04-14 0001193125-20-107163
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 0 2013-11-30 2014 FY 10-K 2015-03-02 0001193125-15-073665
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other USD 0 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 503,000 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 19,000 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 455,000 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 4.85M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 1.50M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 134,000 2020-11-30 2021 FY 10-K 2022-02-22 0000950170-22-001637
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 1.21M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.15 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap Depreciation Depreciation USD 927,000 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 552,695 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 728,374 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap DerivativeAssetsCurrent Derivative Asset, Current USD 122,113 2023-11-30 2024 Q2 10-Q 2024-07-15 0000950170-24-083637
us-gaap DerivativeFairValueOfDerivativeAsset Derivative Asset, Fair Value, Gross Asset USD 0 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 223,974 2023-05-31 2023 Q2 10-Q 2023-07-14 0000950170-23-033057
us-gaap DerivativeFixedInterestRate Derivative, Fixed Interest Rate pure 0.061 2022-08-31 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 0 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap DerivativeNotionalAmount Derivative, Notional Amount USD 8.96M 2022-08-31 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap DividendsCommonStock Dividends, Common Stock USD 2.02M 2024-12-01 2025-02-28 2025 Q1 10-Q 2025-04-14 0000950170-25-053767
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 7.67M 2022-08-31 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.23 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.23 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.04 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.001 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-12-01 2019-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.119 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0.031 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.039 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure 0.024 2021-12-01 2022-11-30 2022 FY 10-K 2023-02-28 0000950170-23-005220
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 0 2012-12-01 2013-02-28 2013 Q1 10-Q 2013-04-15 0001193125-13-155139
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 49,000 2019-05-31 2019 Q2 10-Q 2019-07-15 0001193125-19-194098
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 19,000 2019-08-31 2019 Q3 10-Q 2019-10-15 0001193125-19-267766
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 684,000 2014-12-01 2015-11-30 2016 FY 10-K 2017-02-28 0001193125-17-062739
us-gaap EquityMethodInvestments Equity Method Investments USD 0 2016-11-30 2016 FY 10-K 2017-02-28 0001193125-17-062739
us-gaap EscrowDeposit Escrow Deposit USD 50,000 2022-06-15 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 4.59M 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 16,076 2015-08-31 2015 Q3 10-Q 2015-10-15 0001193125-15-344846
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 641,279 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 44,549 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 13,166 2015-08-31 2015 Q3 10-Q 2015-10-15 0001193125-15-344846
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 43,782 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 44,366 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 44,549 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 44,549 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 34,570 2014-11-30 2014 FY 10-K 2015-03-02 0001193125-15-073665
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 829,611 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 6.88M 2014-12-01 2015-08-31 2016 Q3 10-Q 2016-10-17 0001193125-16-739879
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD -1.07M 2019-12-01 2020-11-30 2021 FY 10-K 2022-02-22 0000950170-22-001637
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap GainLossOnSaleOfSecuritiesNet Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) USD 0 2011-12-01 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 300,593 2015-12-01 2016-11-30 2017 FY 10-K 2018-02-28 0001193125-18-064199
us-gaap Goodwill Goodwill USD 1.94M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 1.99M 2015-12-01 2016-11-30 2017 FY 10-K 2018-02-28 0001193125-18-064199
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 111,392 2016-11-30 2017 FY 10-K 2018-02-28 0001193125-18-064199
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2016-03-01 2016-05-31 2016 Q2 10-Q 2016-07-11 0001193125-16-645605
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 25,649 2013-12-01 2014-11-30 2015 FY 10-K 2016-02-29 0001193125-16-485790
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ImpairmentOfOngoingProject Impairment of Ongoing Project USD 13.11M 2023-09-01 2023-11-30 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 2.72M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 3.85M 2020-12-01 2021-08-31 2021 Q3 10-Q 2021-10-15 0001564590-21-050960
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -18,824 2014-12-01 2015-11-30 2016 FY 10-K 2017-02-28 0001193125-17-062739
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.40M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 851,354 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 1.89M 2011-12-01 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 587,000 2018-12-01 2019-08-31 2019 Q3 10-Q 2019-10-15 0001193125-19-267766
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -2,000 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 3.08M 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -490,803 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 278,211 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 0 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 86,902 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -91,888 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap IncomeTaxReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount USD 80,027 2021-12-01 2022-11-30 2022 FY 10-K 2023-02-28 0000950170-23-005220
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD 2.05M 2010-12-01 2011-11-30 2011 FY 10-K 2012-02-28 0001193125-12-085810
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -449,861 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 911,294 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -1.71M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 3.27M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 3.50M 2017-12-01 2018-08-31 2018 Q3 10-Q 2018-10-15 0001193125-18-299303
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 48,763 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncreaseDecreaseInNotesReceivables Increase (Decrease) in Notes Receivables USD -550,782 2013-12-01 2014-11-30 2015 FY 10-K 2016-02-29 0001193125-16-485790
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -327,646 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 450,979 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -105,045 2013-12-01 2014-08-31 2014 Q3 10-Q 2014-10-15 0001193125-14-372812
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -82,233 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -204,344 2015-12-01 2016-11-30 2017 FY 10-K 2018-02-28 0001193125-18-064199
us-gaap IncreaseDecreaseInRestrictedCashAndInvestments Increase (Decrease) in Restricted Cash and Investments USD 2.50M 2010-12-01 2011-08-31 2011 Q3 10-Q/A 2011-11-07 0001193125-11-299944
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 142 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 829,611 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap InterestCostsCapitalized Interest Costs Capitalized USD 0 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap InterestCostsIncurred Interest Costs Incurred USD 927,605 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap InterestExpense Interest Expense USD 1.34M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap InterestExpenseDebt Interest Expense, Debt USD 18,115 2021-12-01 2022-05-31 2022 Q2 10-Q 2022-07-11 0000950170-22-012605
us-gaap InterestExpenseLongTermDebt Interest Expense, Long-term Debt USD 499,082 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.34M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.33M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap InterestPayableCurrent Interest Payable, Current USD 1.39M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 5,262 2018-11-30 2018 FY 10-K 2019-02-28 0001193125-19-057945
us-gaap InventoryNet Inventory, Net USD 533,557 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 700,000 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 0 2019-08-31 2019 Q3 10-Q 2019-10-15 0001193125-19-267766
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 7,718 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 188,085 2018-11-30 2018 FY 10-K 2019-02-28 0001193125-19-057945
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 30,934 2012-12-01 2013-08-31 2013 Q3 10-Q 2013-10-15 0001193125-13-400021
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 684,000 2014-02-28 2014 Q1 10-Q 2014-04-14 0001193125-14-142721
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 318,587 2019-12-01 2020-11-30 2020 FY 10-K 2021-03-01 0001564590-21-009945
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 455,753 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 38,247 2023-11-30 2023 FY 10-K 2024-02-28 0000950170-24-022275
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 38,175 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 152,700 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 125,350 2025-08-31 2025 Q3 10-Q 2025-10-15 0001193125-25-240385
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 31,250 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap Liabilities Liabilities USD 78.70M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 62.30M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LiabilitiesCurrent Liabilities, Current USD 15.33M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LiabilitiesSubjectToCompromiseEarlyContractTerminationFees Liabilities Subject to Compromise, Early Contract Termination Fees USD 1.86M 2013-08-31 2013 Q3 10-Q 2013-10-15 0001193125-13-400021
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 0 2016-12-01 2017-11-30 2017 FY 10-K 2018-02-28 0001193125-18-064199
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 203,159 2017-12-01 2018-05-31 2018 Q2 10-Q 2018-07-16 0001193125-18-218864
us-gaap LineOfCredit Long-term Line of Credit USD 350,000 2020-06-30 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod Line of Credit Facility, Maximum Amount Outstanding During Period USD 150,000 2020-12-01 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LitigationSettlementAmount Litigation Settlement, Amount (Deprecated 2017-01-31) USD 525,000 2013-12-02 2013-12-31 2015 Q1 10-Q 2015-04-14 0001193125-15-129576
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 3.40M 2015-12-01 2016-11-30 2017 FY 10-K 2018-02-28 0001193125-18-064199
us-gaap LongLivedAssetsHeldForSaleImpairmentCharge Long Lived Assets Held-for-sale, Impairment Charge (Deprecated 2013-01-31) USD 0 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap LongTermAccountsNotesAndLoansReceivableNetNoncurrent Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 550,697 2012-11-30 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap LongTermDebt Long-term Debt USD 8.24M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 7.41M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 210,387 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 242,012 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 253,460 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 238,197 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 223,851 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 199,184 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.43M 2019-05-31 2019 Q2 10-Q 2019-07-15 0001193125-19-194098
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 8.04M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 487,000 2013-08-31 2013 Q3 10-Q 2013-10-15 0001193125-13-400021
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 5.00M 2012-12-01 2013-11-30 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap LossContingencyEstimateOfPossibleLoss Loss Contingency, Estimate of Possible Loss USD 0 2012-11-30 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability USD 1.00M 2012-12-01 2013-11-30 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap MarketableSecurities Marketable Securities USD 807,000 2020-11-30 2020 FY 10-K 2021-03-01 0001564590-21-009945
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 2.80M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD 275,000 2023-12-01 2024-02-29 2024 Q1 10-Q 2024-04-15 0000950170-24-044493
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 99,595 2014-02-28 2014 Q1 10-Q 2014-04-14 0001193125-14-142721
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -98,684 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -2.41M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -497,750 2017-12-01 2018-02-28 2018 Q1 10-Q 2018-04-16 0001193125-18-118744
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -126,608 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -481,866 2017-12-01 2018-02-28 2018 Q1 10-Q 2018-04-16 0001193125-18-118744
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 3.64M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 1.69M 2017-12-01 2018-02-28 2018 Q1 10-Q 2018-04-16 0001193125-18-118744
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -2.43M 2024-12-01 2025-11-30 DEF 14A 2026-10-13 0001193125-26-420608
us-gaap NoncashOrPartNoncashAcquisitionDebtAssumed1 Noncash or Part Noncash Acquisition, Debt Assumed USD 1.30M 2014-12-01 2015-11-30 2016 FY 10-K 2017-02-28 0001193125-17-062739
us-gaap NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 Noncash or Part Noncash Acquisition, Investments Acquired USD 81,480 2013-12-01 2014-11-30 2015 FY 10-K 2016-02-29 0001193125-16-485790
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 20.10M 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 1.41M 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -1.43M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap NotesIssued1 Notes Issued USD 194,000 2011-12-01 2012-08-31 2012 Q3 10-Q 2012-10-15 0001193125-12-423457
us-gaap NotesPayable Notes Payable USD 358,433 2022-05-31 2022 Q2 10-Q 2022-07-11 0000950170-22-012605
us-gaap NotesPayableCurrent Notes Payable, Current USD 199,184 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 3 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 4.16M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 456,204 2024-12-01 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 577,203 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 426,861 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 150,342 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OperatingLeasePayments Operating Lease, Payments USD 395,312 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 529,033 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 290,593 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 224,928 2020-11-30 2020 FY 10-K 2021-03-01 0001564590-21-009945
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 16,133 2015-11-30 2015 FY 10-K 2016-02-29 0001193125-16-485790
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 18,744 2019-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 18,744 2020-11-30 2020 FY 10-K 2021-03-01 0001564590-21-009945
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.075 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 2.13M 2014-11-30 2014 FY 10-K 2015-03-02 0001193125-15-073665
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 4.36M 2025-09-01 2025-11-30 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.08M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 28.59M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 0 2018-12-01 2019-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) USD 94,055 2010-12-01 2011-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2012-01-31) USD -94,055 2010-12-01 2011-11-30 2011 FY 10-K 2012-02-28 0001193125-12-085810
us-gaap OtherInvestmentNotReadilyMarketableFairValue Other Investment Not Readily Marketable, Fair Value USD 0 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 900,000 2011-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 63.37M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 875,000 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 210,258 2013-12-01 2014-11-30 2014 FY 10-K 2015-03-02 0001193125-15-073665
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 8,947 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap OtherSundryLiabilitiesNoncurrent Other Sundry Liabilities, Noncurrent USD 47,020 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 28,364 2018-12-01 2019-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 169,300 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 0 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 10.50M 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 187,500 2013-12-01 2014-11-30 2015 FY 10-K 2016-02-29 0001193125-16-485790
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2021-12-01 2022-11-30 2022 FY 10-K 2023-02-28 0000950170-23-005220
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 150,000 2020-12-01 2021-02-28 2022 Q1 10-Q 2022-04-13 0000950170-22-005662
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 1.03M 2009-12-01 2010-11-30 2011 FY 10-K 2012-02-28 0001193125-12-085810
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD -550,782 2013-12-01 2014-02-28 2014 Q1 10-Q 2014-04-14 0001193125-14-142721
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 201,645 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PaymentsToFundLongtermLoansToRelatedParties Payments to Fund Long-term Loans to Related Parties USD 37,693 2012-12-01 2013-11-30 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PreferredStockRedemptionPricePerShare Preferred Stock, Redemption Price Per Share USD/shares 0.01 2016-08-31 2016 Q3 10-Q 2016-10-17 0001193125-16-739879
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 500,000 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 539,924 2014-08-31 2014 Q3 10-Q 2014-10-15 0001193125-14-372812
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 490,985 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 1.20M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2022-12-01 2023-11-30 2023 FY 10-K 2024-02-28 0000950170-24-022275
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 975,079 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 23,250 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ProductWarrantyAccrualPayments Standard and Extended Product Warranty Accrual, Decrease for Payments USD 100,000 2017-06-01 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 1.87M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 27.60M 2025-11-30 2025 FY 10-K 2026-02-27 0001193125-26-083096
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 20.54M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 923,595 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap RatioOfIndebtednessToNetCapital1 Ratio of Indebtedness to Net Capital pure 3.5 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap RealEstateInvestmentPropertyAtCost Real Estate Investment Property, at Cost USD 1.85M 2022-06-10 2022 Q3 10-Q 2022-10-18 0000950170-22-019626
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 6,759 2010-12-01 2011-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 3.50M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 129,517 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 219,166 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 204,344 2015-11-30 2016 FY 10-K 2017-02-28 0001193125-17-062739
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -36.57M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 23.28M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 63.97M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap Revenues Revenues USD 12.75M 2017-12-01 2018-05-31 2018 Q2 10-Q 2018-07-16 0001193125-18-218864
us-gaap RoyaltyExpense Royalty Expense USD 112,830 2016-12-01 2017-11-30 2017 FY 10-K 2018-02-28 0001193125-18-064199
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 1.87M 2013-12-01 2014-11-30 2014 FY 10-K 2015-03-02 0001193125-15-073665
us-gaap SalesCommissionsAndFees Sales Commissions and Fees USD 20,896 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 12.50M 2017-12-01 2018-05-31 2018 Q2 10-Q 2018-07-16 0001193125-18-218864
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 13.41M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 315,967 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 171,000 2012-12-01 2013-11-30 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2017-12-01 2018-08-31 2018 Q3 10-Q 2018-10-15 0001193125-18-299303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2017-12-01 2018-08-31 2018 Q3 10-Q 2018-10-15 0001193125-18-299303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 51,636 2017-12-01 2018-08-31 2018 Q3 10-Q 2018-10-15 0001193125-18-299303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.58 2012-12-01 2013-11-30 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 40,254 2018-08-31 2018 Q3 10-Q 2018-10-15 0001193125-18-299303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 3.06 2018-08-31 2018 Q3 10-Q 2018-10-15 0001193125-18-299303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 50,550 2017-12-01 2018-08-31 2018 Q3 10-Q 2018-10-15 0001193125-18-299303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 1.05M 2011-12-01 2012-08-31 2012 Q3 10-Q 2012-10-15 0001193125-12-423457
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 2.73 2017-12-01 2018-08-31 2018 Q3 10-Q 2018-10-15 0001193125-18-299303
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.53M 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 959,552 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2015-12-01 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2015-12-01 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 0 2020-12-01 2021-02-28 2021 Q1 10-Q 2021-04-14 0001564590-21-018845
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 112,755 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.19 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 152,525 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 0 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 0 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 1.97 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.53M 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 968,930 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.17 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 14,000 2018-12-01 2019-08-31 2020 Q3 10-Q 2020-10-15 0001564590-20-046540
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 88,377 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 1.9 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2015-12-01 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2015-12-01 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2015-12-01 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 6.71 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 507,708 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 660,233 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 6.38 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap SponsorFees Sponsor Fees USD 7,000 2014-12-01 2015-11-30 2015 FY 10-K 2016-02-29 0001193125-16-485790
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -16.39M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap StockIssued1 Stock Issued USD 0 2021-12-01 2022-11-30 2022 FY 10-K 2023-02-28 0000950170-23-005220
us-gaap StockIssuedDuringPeriodSharesIssuedForNoncashConsideration Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration (Deprecated 2015-01-31) shares 0 2011-12-01 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture shares 0 2013-12-01 2014-08-31 2014 Q3 10-Q 2014-10-15 0001193125-14-372812
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2015-12-01 2016-05-31 2016 Q2 10-Q 2016-07-11 0001193125-16-645605
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.59M 2020-12-01 2021-11-30 2022 FY 10-K 2023-02-28 0000950170-23-005220
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 23,250 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 9.87M 2016-06-20 2017 FY 10-K 2018-02-28 0001193125-18-064199
us-gaap StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Number of Shares Authorized to be Repurchased shares 8.00M 2016-10-06 2024 Q1 10-Q 2024-04-15 0000950170-24-044493
us-gaap SupplementalUnemploymentBenefits Supplemental Unemployment Benefits USD 980,938 2013-06-14 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD 0 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) USD 3.10M 2016-12-01 2017-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap TradingSecurities Debt Securities, Trading, and Equity Securities, FV-NI USD 37,910 2013-11-30 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap TradingSecuritiesCurrent Trading Securities, Current (Deprecated 2014-01-31) USD 20,760 2012-11-30 2012 FY 10-K 2013-02-28 0001193125-13-084813
us-gaap TradingSecuritiesEquity Trading Securities, Equity USD 0 2013-02-28 2013 Q1 10-Q 2013-04-15 0001193125-13-155139
us-gaap TradingSecuritiesUnrealizedHoldingGain Trading Securities, Unrealized Holding Gain USD 15,525 2013-12-01 2014-02-28 2014 Q1 10-Q 2014-04-14 0001193125-14-142721
us-gaap TradingSecuritiesUnrealizedHoldingGainLoss Trading Securities, Change in Unrealized Holding Gain (Loss) USD 28,000 2017-12-01 2018-11-30 2019 FY 10-K 2020-02-28 0001193125-20-056695
us-gaap TradingSecuritiesUnrealizedHoldingLoss Trading Securities, Unrealized Holding Loss USD 7,100 2011-12-01 2012-11-30 2013 FY 10-K 2014-02-28 0001193125-14-077783
us-gaap TreasuryStockAcquiredAverageCostPerShare Treasury Stock Acquired, Average Cost Per Share USD/shares 3.08 2015-12-01 2016-05-31 2016 Q2 10-Q 2016-07-11 0001193125-16-645605
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 6.82M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap TreasuryStockNumberOfSharesHeld Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) shares 3.38M 2016-02-29 2016 Q1 10-Q 2016-04-14 0001193125-16-541409
us-gaap TreasuryStockShares Treasury Stock, Shares shares 6.56M 2023-05-31 2023 Q2 10-Q 2023-07-14 0000950170-23-033057
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 143,793 2015-12-01 2016-05-31 2016 Q2 10-Q 2016-07-11 0001193125-16-645605
us-gaap TreasuryStockValue Treasury Stock, Value USD 25.03M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 169,502 2024-12-01 2025-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 591 2022-05-31 2022 Q2 10-Q 2022-07-11 0000950170-22-012605
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 70,000 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition USD 0 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2023-12-01 2024-11-30 2024 FY 10-K 2025-02-28 0000950170-25-030138
us-gaap ValuationAllowanceAmount Valuation Allowance, Amount (Deprecated 2013-01-31) USD 10.54M 2012-08-31 2012 Q3 10-Q 2012-10-15 0001193125-12-423457
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 8.06M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 8.06M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001193125-26-419156

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →